U.S. Agent vs. Initial Importer: A Critical Choice for FDA Import Success cover art

U.S. Agent vs. Initial Importer: A Critical Choice for FDA Import Success

U.S. Agent vs. Initial Importer: A Critical Choice for FDA Import Success

Listen for free

View show details

About this listen

 This episode demystifies the distinct and critical roles of the FDA U.S. Agent and the Initial Importer for medical device manufacturers entering the U.S. market. We explore the specific regulatory responsibilities of each, highlighting why appointing a distributor without proven compliance expertise can jeopardize your import success and post-market standing. • What is the fundamental difference between an FDA U.S. Agent and an Initial Importer? • Who is legally responsible for reporting adverse device events to the FDA? • Can your distributor also act as your Initial Importer? • What are the risks of choosing an Initial Importer without proven regulatory processes? • Which entity is responsible for verifying a device's 510(k) or PMA status upon import? • How do these roles directly impact whether your shipments clear U.S. customs? • What specific post-market surveillance duties does an Initial Importer have? • Why is this distinction crucial for maintaining compliance once your device is in the U.S. market? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.